• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱梭形细胞和巨细胞癌。3例报告。

Spindle and giant cell carcinoma of the bladder. Report of 3 cases.

作者信息

Komatsu H, Kinoshita K, Mikata N, Honma Y

出版信息

Eur Urol. 1985;11(2):141-4. doi: 10.1159/000472476.

DOI:10.1159/000472476
PMID:4007005
Abstract

3 cases of spindle and giant cell carcinoma are reported. 2 patients with T3N0M0 and T3N1M0 tumors underwent radical cystectomy. They died 8 and 9 months after cystectomy for local recurrence and tumor metastases. Neither radiotherapy nor chemotherapy were effective in these 2 patients. 1 patient with T1NXM0 disease underwent resection of the tumor through cystotomy. Although she had neither adjuvant chemotherapy nor radiotherapy, she is well without recurrence 6 years after surgery. Early surgical resection of the tumor may be the only currently accepted therapy of spindle and giant cell carcinoma of the bladder.

摘要

报告了3例梭形细胞和巨细胞癌。2例患有T3N0M0和T3N1M0肿瘤的患者接受了根治性膀胱切除术。他们在膀胱切除术后8个月和9个月因局部复发和肿瘤转移死亡。放疗和化疗对这2例患者均无效。1例患有T1NXM0疾病的患者通过膀胱切开术切除了肿瘤。尽管她既没有接受辅助化疗也没有接受放疗,但术后6年病情良好,无复发。肿瘤的早期手术切除可能是目前唯一被认可的膀胱梭形细胞和巨细胞癌治疗方法。

相似文献

1
Spindle and giant cell carcinoma of the bladder. Report of 3 cases.膀胱梭形细胞和巨细胞癌。3例报告。
Eur Urol. 1985;11(2):141-4. doi: 10.1159/000472476.
2
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.浸润性膀胱癌的新辅助化疗和部分膀胱切除术
J Clin Oncol. 1994 May;12(5):975-80. doi: 10.1200/JCO.1994.12.5.975.
3
Management of superficial bladder carcinoma: time to rethink the treatment strategies in the era of orthotopic neo-bladder.浅表性膀胱癌的管理:是时候重新思考原位新膀胱时代的治疗策略了。
Saudi J Kidney Dis Transpl. 2010 Sep;21(5):881-5.
4
Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.经尿道切除术、化疗和放疗联合选择性膀胱保留:保留膀胱内Ta、T1和Tis期复发的管理及后果
Urology. 2001 Sep;58(3):380-5. doi: 10.1016/s0090-4295(01)01219-5.
5
Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.临床分期为T2期膀胱癌的同步放化疗:单机构报告
Urology. 2004 Jan;63(1):73-7. doi: 10.1016/j.urology.2003.09.018.
6
Invasive bladder cancer: our experience with bladder sparing approach.
Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):273-8. doi: 10.1016/s0360-3016(98)00013-3.
7
Solitary brain metastases from carcinoma of the bladder.
J Neurooncol. 1993 Jun;16(3):217-20. doi: 10.1007/BF01057036.
8
Bladder-sparing therapy for muscle-infiltrating bladder cancer.肌肉浸润性膀胱癌的保膀胱治疗
Nat Clin Pract Urol. 2008 Jul;5(7):368-75. doi: 10.1038/ncpuro1145. Epub 2008 Jun 17.
9
[Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].[局部晚期膀胱癌的保守治疗:新辅助化疗、经尿道切除术和放射治疗。40例患者的结果]
Arch Ital Urol Androl. 1998 Jun;70(3 Suppl):37-40.
10
Can patient selection for bladder preservation be based on response to chemotherapy?保膀胱治疗的患者选择能否基于化疗反应?
Cancer. 2003 Apr 1;97(7):1644-52. doi: 10.1002/cncr.11232.

引用本文的文献

1
Pleomorphic carcinoma of breast: a case report and review of literature.乳腺多形性癌:一例病例报告及文献复习
Int J Clin Exp Pathol. 2014 Jul 15;7(8):5215-20. eCollection 2014.